Harrow Newsroom

Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating

Moomoo NewsApr 11 02:32 ET

B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $65

Moomoo NewsApr 2 02:31 ET

Harrow Is Maintained at Buy by B. Riley Securities

Dow JonesApr 1 13:31 ET

Harrow Price Target Cut to $65.00/Share From $69.00 by B. Riley Securities

Dow JonesApr 1 13:31 ET

H.C. Wainwright Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $57

Moomoo NewsApr 1 02:33 ET

Harrow Analyst Ratings

BenzingaMar 31 06:58 ET

Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating

Moomoo NewsMar 29 02:32 ET

Harrow Health (HROW) Gets a Buy From Craig-Hallum

TipRanksMar 28 08:54 ET

Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating

Moomoo NewsMar 25 02:32 ET

Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsMar 25 02:32 ET

Lake Street Sticks to Their Buy Rating for Harrow Health (HROW)

TipRanksMar 24 09:12 ET

H.C. Wainwright Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $57

Moomoo NewsMar 19 02:31 ET

Harrow Analyst Ratings

BenzingaMar 18 13:05 ET

Harrow Health: Strong Financial Performance and Strategic Initiatives Drive Buy Rating With 40% Revenue Growth Outlook

TipRanksMar 18 12:09 ET

Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating

Moomoo NewsMar 18 02:31 ET

Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsMar 18 02:31 ET

Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating

Moomoo NewsMar 12 07:31 ET

Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsMar 12 07:31 ET

Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Tenaya Therapeutics (TNYA) and TruBridge (TBRG)

TipRanksMar 11 09:29 ET

H.C. Wainwright Initiates Harrow(HROW.US) With Buy Rating, Announces Target Price $57

Moomoo NewsFeb 6 06:32 ET